rs367589841
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_002047.4(GARS1):c.1543G>A(p.Val515Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
GARS1
NM_002047.4 missense
NM_002047.4 missense
Scores
4
11
3
Clinical Significance
Conservation
PhyloP100: 5.72
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 7-30622392-G-A is Benign according to our data. Variant chr7-30622392-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 577795.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000131 (20/152200) while in subpopulation AFR AF= 0.000482 (20/41454). AF 95% confidence interval is 0.00032. There are 0 homozygotes in gnomad4. There are 9 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 20 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARS1 | NM_002047.4 | c.1543G>A | p.Val515Met | missense_variant | 12/17 | ENST00000389266.8 | NP_002038.2 | |
GARS1 | NM_001316772.1 | c.1381G>A | p.Val461Met | missense_variant | 12/17 | NP_001303701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1543G>A | p.Val515Met | missense_variant | 12/17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1543G>A | p.Val515Met | missense_variant | 12/17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.1441G>A | p.Val481Met | missense_variant | 11/16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.1375G>A | p.Val459Met | missense_variant | 13/18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.1342G>A | p.Val448Met | missense_variant | 12/17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.1174G>A | p.Val392Met | missense_variant | 12/17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.1174G>A | p.Val392Met | missense_variant | 13/18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.1543G>A | non_coding_transcript_exon_variant | 12/18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*1257G>A | non_coding_transcript_exon_variant | 13/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*643G>A | non_coding_transcript_exon_variant | 13/17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*881G>A | non_coding_transcript_exon_variant | 13/18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.1543G>A | non_coding_transcript_exon_variant | 12/16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1413G>A | non_coding_transcript_exon_variant | 13/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.1543G>A | non_coding_transcript_exon_variant | 12/15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1485G>A | non_coding_transcript_exon_variant | 14/19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*488G>A | non_coding_transcript_exon_variant | 12/17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*994G>A | non_coding_transcript_exon_variant | 12/17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*832G>A | non_coding_transcript_exon_variant | 13/18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*975G>A | non_coding_transcript_exon_variant | 12/17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.1543G>A | non_coding_transcript_exon_variant | 12/16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*1257G>A | 3_prime_UTR_variant | 13/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*643G>A | 3_prime_UTR_variant | 13/17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*881G>A | 3_prime_UTR_variant | 13/18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000675529.1 | n.*1413G>A | 3_prime_UTR_variant | 13/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*1485G>A | 3_prime_UTR_variant | 14/19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*488G>A | 3_prime_UTR_variant | 12/17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*994G>A | 3_prime_UTR_variant | 12/17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*832G>A | 3_prime_UTR_variant | 13/18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*975G>A | 3_prime_UTR_variant | 12/17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152200Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
20
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249566Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135396
GnomAD3 exomes
AF:
AC:
6
AN:
249566
Hom.:
AF XY:
AC XY:
3
AN XY:
135396
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461834Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727222
GnomAD4 exome
AF:
AC:
10
AN:
1461834
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74354
GnomAD4 genome
AF:
AC:
20
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
3
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The p.V515M variant (also known as c.1543G>A), located in coding exon 12 of the GARS gene, results from a G to A substitution at nucleotide position 1543. The valine at codon 515 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, this variant is unlikely to be causative of Charcot-Marie Tooth type 2D (CMT2D) and distal hereditary motor neuronopathy type VA; however, its contribution to the development of GARS-related mitochondrial respiratory chain dysfunction is uncertain. - |
Charcot-Marie-Tooth disease type 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 22, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
T
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Pathogenic
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at